⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2118069 | 1.00 | — | — | |
| SCHEMBL8960984 | 0.78 | GRIK1 (0.31) | — | |
| SCHEMBL8960989 | 0.78 | GRIK1 (0.31) | — | |
| SCHEMBL5881309 | 0.78 | GRIK1 (0.32) | — | |
| SCHEMBL8960700 | 0.77 | — | — | |
| SCHEMBL8960694 | 0.77 | — | — | |
| SCHEMBL8960619 | 0.76 | — | — | |
| SCHEMBL8960622 | 0.76 | — | — | |
| SCHEMBL5985953 | 0.75 | — | — | |
| SCHEMBL5985957 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250218-A1 | URETHANE COMPOSITION | NITTO KASEI CO., LTD. (JP) | 2023-08-10 | — | — | US | disclosed |
| EP-4198068-A1 | URETHANE COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2023-06-21 | — | — | EP | disclosed |
| CN-116018365-A | Carbamate composition | 日东化成株式会社 | 2023-04-25 | — | — | CN | disclosed |
| US-20230082311-A1 | DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL ALPORT SYNDROME | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2023-03-16 | — | — | US | disclosed |
| EP-4029514-A1 | DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL ALPORT SYNDROME | National University Corporation Kumamoto University (JP) | 2022-07-20 | — | — | EP | disclosed |
| CN-114761033-A | Medicament for radical therapy of refractory hereditary nephrotic Alport syndrome | 国立大学法人熊本大学 | 2022-07-15 | — | — | CN | disclosed |
| EP-3986394-A1 | BIOFILM DISRUPTION | QBiotics Pty Ltd (AU) | 2022-04-27 | — | — | EP | disclosed |
| WO-2021049633-A1 | DRUG FOR CURATIVE THERAPY OF INTRACTABLE HEREDITARY RENAL ALPORT SYNDROME | 国立大学法人熊本大学 | 2021-03-18 | — | — | WO | disclosed |
| WO-2020252535-A1 | BIOFILM DISRUPTION | QBiotics Pty Ltd (AU) | 2020-12-24 | — | — | WO | disclosed |
| CN-107949625-B | Hydrocarbon soluble/dispersible hemiformals as hydrogen sulfide scavengers | 艺康美国股份有限公司 | 2020-10-02 | — | — | CN | disclosed |
| EP-0330025-A2 | Antidiabetic composition comprising isocarbacyclin derivative | TEIJIN LIMITED (JP) | 1989-08-30 | — | — | EP | disclosed |
| US-4847259-A | Nitrogen-containing heterocyclic compounds, and use as insecticide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1989-07-11 | — | — | US | disclosed |
| US-4837342-A | STABILITY | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-06-06 | — | — | US | disclosed |
| EP-0173754-B1 | 7-THIAPROSTAGLANDIN E 1?'S AND PROCESS FOR THEIR PREPARATION | TEIJIN LIMITED (JP) | 1989-04-26 | — | — | EP | disclosed |
| US-4755598-A | 1'-(substituted)ethyl-7β-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-(2-dimethylaminoethyl)-1H-tetrazol-5-yl]thio]methyl]ceph-3-em-4-carboxylate derivatives having antibacterial utility | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-07-05 | — | — | US | disclosed |
| US-4714706-A | JUVENILE HORMONE INHIBITORS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-12-22 | — | — | US | disclosed |
| EP-0234576-A1 | Prostacyclin analogue, and blood circulation improving agent and anti-ulcer composition containing it as active ingredient | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1987-09-02 | — | — | EP | disclosed |
| EP-0203798-A2 | Nitrogen-containing heterocyclic compounds, and their production and use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-12-03 | — | — | EP | disclosed |
| EP-0173754-A1 | 7-THIAPROSTAGLANDIN E 1?'S AND PROCESS FOR THEIR PREPARATION | TEIJIN LIMITED (JP) | 1986-03-12 | — | — | EP | disclosed |
| EP-0128028-A2 | Cephalosporin derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1984-12-12 | — | — | EP | disclosed |